Incyte Corp (NASDAQ:INCY)

67.83
Delayed Data
As of May 18
 +1.19 / +1.79%
Today’s Change
60.23
Today|||52-Week Range
140.11
-28.38%
Year-to-Date
No recent news for Incyte Corp.

Today’s Trading

Previous close66.64
Today’s open66.77
Day’s range66.50 - 68.13
Volume1,768,573
Average volume (3 months)2,391,656
Market cap$14.2B
Data as of 4:00pm ET, 05/18/2018

Growth & Valuation

Earnings growth (last year)-383.33%
Earnings growth (this year)+117.88%
Earnings growth (next 5 years)+63.90%
Revenue growth (last year)+38.93%
P/E ratioNM
Price/Sales12.61
Price/Book8.71

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc+1.45+1.75%
ALXNAlexion Pharmaceutic...-0.08-0.07%
BAXBaxter International...-0.05-0.07%
MYLMylan NV-0.42-1.05%
Data as of 4:15pm ET, 05/18/2018

Financials

Next reporting dateAugust 2, 2018
EPS forecast (this quarter)$0.19
Annual revenue (last year)$1.5B
Annual profit (last year)-$313.1M
Net profit margin-20.38%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts